Are you Dr. Botson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 80 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3890 University Lake Dr Ste 110
Anchorage, AK 99508Phone+1 907-562-2277Fax+1 907-563-3460
Summary
- Dr. John Botson, MD is a rheumatologist in Anchorage, Alaska. He is currently licensed to practice medicine in Alaska, Hawaii, and Maryland. He is affiliated with Providence Alaska Medical Center, Alaska Regional Hospital, and Mat-Su Regional Medical Center.
Education & Training
- National Institutes of Health Clinical CenterFellowship, Rheumatology, 2007 - 2009
- Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 2004 - 2007
- Ohio State University College of MedicineClass of 2004
Certifications & Licensure
- HI State Medical License 2021 - 2026
- OH State Medical License 2000 - 2025
- AK State Medical License 2007 - 2024
- NH State Medical License 2004 - 2024
- MD State Medical License 2007 - 2011
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- 32 citationsPegloticase in Combination With Methotrexate in Patients With Uncontrolled Gout: A Multicenter, Open-label Study (MIRROR)John K. Botson, John Tesser, Ralph Bennett, Howard M. Kenney, Paul M. Peloso
The Journal of Rheumatology. 2021-05-01 - 13 citationsDual-energy CT assessment of rapid monosodium urate depletion and bone erosion remodelling during pegloticase plus methotrexate co-therapy.Nicola Dalbeth, Fabio Becce, John K Botson, Lin Zhao, Ada Kumar
Rheumatology. 2022-11-28 - 23 citationsThe effect of immunomodulators on the efficacy and tolerability of pegloticase: a systematic review.Robert T. Keenan, John K. Botson, Karim R. Masri, Lissa Padnick-Silver, Brian LaMoreaux
Seminars in Arthritis and Rheumatism. 2021-04-01
Press Mentions
- Options for Refractory Gout, ILD & MoreNovember 18th, 2022
- Combination Therapy Effective for Hard-to-Treat Patients with GoutNovember 14th, 2022
- Twelve-Month Data Back Pegloticase-Methotrexate Gout ComboNovember 13th, 2022
- Join now to see all
Professional Memberships
- Member
- Fellow